Depression and Anxiety in Patients with Multiple Sclerosis (MS): A Systematic Review (In press)

Authors

  • Adele Isanazar Department of Psychiatry, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
  • Maryam Vaghari Department of Psychology, Faculty of Humanities, Rasht Branch, Islamic Azad University, Rasht, Iran.
  • Mozaffar Hosseininezhad Department of Neurology, Associate Professor, Neurosciences Research Center, Department of Neurology, Guilan University of Medical Sciences, Rasht, Iran.
  • Sajjad Saadat Ph.D in Psychology, Neurosciences Research Center, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
  • Shahrzad Hoodinshad Department of Psychology, Faculty of Humanities, Tehran North Branch, Islamic Azad University, Tehran, Iran.
Abstract:

Background: Multiple Sclerosis (MS) is considered as one of the most prevalent chronic and progressive neurological diseases that has high simultaneity with some psychological disorders such as depression and anxiety; we examined depression and anxiety in people suffering from MS in this review study.  Methods: We conducted this study using a systematic review method relying on the search from January 2010 to December 2020 and also searched keywords of multiple sclerosis, MS, psychiatric issues, psychological disorders, psychological problems, anxiety, mental health, quality of life and depression in four online databases (PsycNET, PubMed and Scopus, Magiran). Ultimately, we selected 14 comprehensive papers that examined psychiatric disorders in patients with MS quantitatively and qualitatively to analyze them in order to achieved the wanted results. Results: A total of 14 studies was analyzed that included 27,106 patients with MS. The results achieved by the analytical studies explained that depression and anxiety are significantly higher in patients with MS compared to healthy people. The prevalence of depression and anxiety in MS patients has been reported to be heterogeneous. Conclusion: Data related to a large number of patients with MS show a high prevalence of depression and anxiety in them, but it is possible that not separating the symptoms from the disorder be misleading. Consequently, it is recommended to conduct further research in order to precisely assess the prevalence of depression and anxiety as a disorder in these patients. It is required that future studies consider more the use of clinical interviews instead of self-reported questionnaires, sample selection methods, and providing a complete report of patients' demographic and clinical information.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Multimodal Psychotherapy in Patients with Multiple Sclerosis (MS)

Objective: The main purpose of this study was to investigate the effectiveness of Lazarus Multimodal Psychotherapy (MMT) on perceived stress in individuals with Multiple Sclerosis (MS). Methods: Through a quasi-experimental design, forty patients in Qazvin city in Iran were selected by convenient sampling and then divided into two groups: experimental and control groups. After group assignme...

full text

Psychological Distress in Patients With Multiple Sclerosis and Epilepsy in the COVID-19 Pandemic: A Systematic Review

Background: The COVID-19 pandemic can cause various anxiety, fear, and tension in society. The negative impact of the pandemic is not limited to physical health problems. It can generate serious consequences, such as anxiety, depression, and stress, especially neurological diseases.  Objectives: The present study investigated depression, anxiety, and stress in patients with MS and epilepsy dur...

full text

The Effectiveness of Yoga Therapy in Reducing Anxiety, Stress and Depression in Women with Multiple Sclerosis

Background: Multiple sclerosis (MS) is a progressive chronic neurologic disorder which topically causes the destruction and inflammation of the myelin sheath in the brain and the spinal cord. It also affects the patient's emotions and can be treated using complementary medicine. Objectives: The present study was conducted to investigate the effectiveness of yoga therapy in reducing anxiety, st...

full text

The Relation between Perceived Social Support with Depression, Anxiety and Stress (DAS) in Patients with Multiple Sclerosis

Background: Multiple sclerosis (MS) is an autoimmune disease of the central nervous system. Psychological manifestations such as depression, anxiety and stress are common in patients with MS. Social support is involved in the well-being of patients with MS. This study aimed to assess the relation between perceived social support with depression, anxiety and stress in patients with MS. Methods:...

full text

Update on riboflavin and multiple sclerosis: a systematic review

Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). Riboflavin plays an important role in myelin formation, and its deficiency is implicated as a risk factor for multiple sclerosis. Here, we systematically reviewed the literature concerning the health benefits of riboflavin on MS. The literature recorded within four main databases, including rel...

full text

the efficacy of group reality therapy on reducing stress, anxiety and depression in patients with multiple sclerosis (ms)

abstract background and objective : psychological aspects of chronic diseases has attracted many professionals. because the incidence of sudden and uncontrollable symptoms of many diseases, causing stress and create a variety of negative emotions and mood in patients'. the purpose of this study was to investigate the effectiveness of group reality therapy in reduceing stress, anxiety and depres...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 7  issue None

pages  0- 0

publication date 2021-10

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023